Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Immunotope

Immunotope
2002 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of immunotherapy products created for the treatment and prevention of cancer and chronic viral infections. The company's immunotherapy platform provides the ideal combination of technologies for successful immunotherapy, use the exquisite sensitivity and specificity of the immune system for early detection of cancer, provide innovative tools and services for collaborative development of novel drug and diagnostic products, enabling patients with effective treatments that destroy tumors and prevent metastasis.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • The Pennsylvania Biotechnology Center
  • 3805 Old Easton Road
  • Doylestown, PA 18901
  • United States

+1 (251) 000-0000

Immunotope Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Immunotope‘s full profile, request access.

Request full access to PitchBook

Immunotope Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Forma Therapeutics Formerly VC-backed Watertown, MA 000 00000 000000&0 00000
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
0000000 Venture Capital-Backed Cambridge, MA 0000 00000000000 0000
00000 000000000 Formerly VC-backed South San Francisco, CA 00 0000 000000&0 0000
000000000 Formerly VC-backed Modi'in, Israel 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Immunotope Executive Team (2)

Name Title Board
Seat
Contact
Info
Ramila Philip Ph.D Co-Founder, President & Chief Scientific Officer
Mohan Philip Ph.D Chief Operating Officer & Co-Founder